Payments to Acquire Property, Plant, and Equipment of OCULAR THERAPEUTIX, INC from 31 Dec 2012 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
OCULAR THERAPEUTIX, INC annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2012 to 31 Dec 2025.
  • OCULAR THERAPEUTIX, INC Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $1,933,000, a 658% increase year-over-year.
  • OCULAR THERAPEUTIX, INC annual Payments to Acquire Property, Plant, and Equipment for 2025 was $12,010,000, a 832% increase from 2024.
  • OCULAR THERAPEUTIX, INC annual Payments to Acquire Property, Plant, and Equipment for 2024 was $1,288,000, a 79% decline from 2023.
  • OCULAR THERAPEUTIX, INC annual Payments to Acquire Property, Plant, and Equipment for 2023 was $6,087,000, a 64% increase from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

OCULAR THERAPEUTIX, INC Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $12,010,000 +$10,722,000 +832% 01 Jan 2025 31 Dec 2025 10-K 05 Feb 2026 2025 FY
2024 $1,288,000 -$4,799,000 -79% 01 Jan 2024 31 Dec 2024 10-K 05 Feb 2026 2025 FY
2023 $6,087,000 +$2,372,000 +64% 01 Jan 2023 31 Dec 2023 10-K 05 Feb 2026 2025 FY
2022 $3,715,000 +$2,521,000 +211% 01 Jan 2022 31 Dec 2022 10-K 03 Mar 2025 2024 FY
2021 $1,194,000 +$353,000 +42% 01 Jan 2021 31 Dec 2021 10-K 11 Mar 2024 2023 FY
2020 $841,000 -$1,397,000 -62% 01 Jan 2020 31 Dec 2020 10-K 06 Mar 2023 2022 FY
2019 $2,238,000 +$349,000 +18% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
2018 $1,889,000 -$6,363,000 -77% 01 Jan 2018 31 Dec 2018 10-K 12 Mar 2020 2019 FY
2017 $8,252,000 +$6,333,000 +330% 01 Jan 2017 31 Dec 2017 10-K 12 Mar 2020 2019 FY
2016 $1,919,000 +$141,000 +7.9% 01 Jan 2016 31 Dec 2016 10-K 07 Mar 2019 2018 FY
2015 $1,778,000 +$518,000 +41% 01 Jan 2015 31 Dec 2015 10-K 08 Mar 2018 2017 FY
2014 $1,260,000 +$873,000 +226% 01 Jan 2014 31 Dec 2014 10-K 10 Mar 2017 2016 FY
2013 $387,000 +$184,000 +91% 01 Jan 2013 31 Dec 2013 10-K 10 Mar 2016 2015 FY
2012 $203,000 01 Jan 2012 31 Dec 2012 10-K 20 Mar 2015 2014 FY

OCULAR THERAPEUTIX, INC Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $1,933,000 +$1,678,000 +658% 01 Jan 2025 31 Mar 2025 10-Q 05 May 2025 2025 Q1
Q1 2024 $255,000 -$3,124,000 -92% 01 Jan 2024 31 Mar 2024 10-Q 05 May 2025 2025 Q1
Q1 2023 $3,379,000 +$3,103,000 +1124% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q1 2022 $276,000 +$118,000 +75% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023 2023 Q1
Q1 2021 $158,000 -$91,000 -37% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q1 2020 $249,000 -$476,000 -66% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021 2021 Q1
Q1 2019 $725,000 +$344,000 +90% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020 2020 Q1
Q1 2018 $381,000 -$1,273,000 -77% 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019 2019 Q1
Q1 2017 $1,654,000 +$1,527,000 +1202% 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018 2018 Q1
Q1 2016 $127,000 -$227,000 -64% 01 Jan 2016 31 Mar 2016 10-Q 05 May 2017 2017 Q1
Q1 2015 $354,000 +$57,000 +19% 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016 2016 Q1
Q1 2014 $297,000 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015 2015 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.